Judit Bedekovics Selected Research

Judit Bedekovics Research Topics

6	Neoplasms (Cancer) 01/2022 - 12/2014
5	Primary Myelofibrosis (Myelosclerosis) 04/2018 - 07/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2014 - 05/2009
2	Hypoxia (Hypoxemia) 07/2019 - 04/2019
2	Hodgkin Disease (Hodgkin's Disease) 07/2019 - 04/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 09/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017 - 09/2015
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Epistaxis (Nosebleed) 12/2021
1	Hemorrhage 12/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	Acidosis 04/2019
1	Lymphoma (Lymphomas) 01/2017
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Fibrosis (Cirrhosis) 11/2015
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2014
1	Residual Neoplasm 04/2014

4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2015 - 07/2013
2	Carbonic Anhydrase IXIBA 07/2019 - 04/2019
2	Histones (Histone)IBA 01/2018 - 01/2017
2	Biological ProductsIBA 09/2015 - 05/2009
2	NucleophosminIBA 01/2013 - 05/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	AnticoagulantsIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	LigandsIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	IsoenzymesIBA 04/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2018
1	Reticulin (Reticular Fiber)IBA 11/2015
1	MEF2 Transcription FactorsIBA 09/2015
1	Formaldehyde (Formol)FDA Link 12/2014
1	ParaffinIBA 12/2014
1	AntigensIBA 12/2014
1	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2014
1	SilverIBA 07/2013

2	Therapeutics 12/2021 - 12/2014
1	Blood Transfusion (Blood Transfusions) 12/2021